You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (9) |
Back to Search
EARLY HEMODIALYSIS IMPROVED CLINICAL OUTCOMES IN A CASE OF LIFE-THREATENING VALPROIC ACID POISONING
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-025
- By: LEE, Ching-Fen (Chang Gung Memorial Hospital-Linkou, Tao-yuan ,Taiwan, Division of Clinical Pharmacy, Department of Pharmacy, China Taiwan)
- Co-author(s): Ching-Fen Lee: Division of Clinical Pharmacy, Department of Pharmacy, Chang Gung Memorial Hospital-Linkou, Tao-yuan , Taiwan, Taoyuan, China Taiwan
Shin-Tarng Deng: Division of Clinical Pharmacy, Department of Pharmacy, Chang Gung Memorial Hospital-Linkou, Tao-yuan , Taiwan, Taoyuan, China Taiwan
Tzu-Cheng Tsai: Division of Clinical Pharmacy, Department of Pharmacy, Chang Gung Memorial Hospital-Linkou, Tao-yuan , Taiwan, Taoyuan, China Taiwan - Abstract:
Background
Valproic acid (VPA) is used as an antiepileptic drug and a mood stabilizer. Therapeutic serum concentrations of VPA range from 50 to 100 mg/L. Levels > 450 mg/L have been found to cause severe life-threatening clinical manifestations such as severe central nervous system (CNS) depression, hyperammonemia, and cerebral edema which can be.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026